Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis
Journal of Bone and Mineral Research,
Boonen S et al. – This analysis shows that zoledronic acid offered significant protection from clinical fractures as early as 12 months. When administered annually, its beneficial effects persisted for at least 3 years.